SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Alfacell (ACEL)
ACEL 11.28+1.0%Feb 6 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Gil Kempenich who wrote (551)7/1/1997 8:01:00 PM
From: r. parker griff   of 1533
 
dear gill
I too am an oncologist and i believe you have heard or seen the light.
there is much truth to what the canadian says Lillys drug is not traditionally
therapeutic. Onconase is in fact cytotoxic and cidal. I feel that when the data is in
and the FDA has reviewed onconase will be approved for both MESO and PAN.

IN MY OPINION ONCONASE IS A WONDERFULL ADDITION TO THE ONCOLOGIST ARSENAL.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News